Clinical Trials
5
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)β’ Click on a phase to view related trials
A Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects
- First Posted Date
- 2010-02-12
- Last Posted Date
- 2012-04-06
- Lead Sponsor
- Topaz Pharmaceuticals Inc
- Target Recruit Count
- 371
- Registration Number
- NCT01068158
- Locations
- πΊπΈ
Arkansas Pediatric Clinic, Little Rock, Arkansas, United States
πΊπΈLice Cleanique, LLC, Delray Beach, Florida, United States
πΊπΈHill Top Research, St Petersburg, Florida, United States
A Safety and Efficacy Study Comparing 0.5% Ivermectin Cream to a Vehicle Control in Subjects With Head Lice Infestation
- First Posted Date
- 2010-02-10
- Last Posted Date
- 2012-04-06
- Lead Sponsor
- Topaz Pharmaceuticals Inc
- Target Recruit Count
- 410
- Registration Number
- NCT01066585
- Locations
- πΊπΈ
Cactus Kids Pediatrics, Yuma, Arizona, United States
πΊπΈUniversal Biopharma Research, Inc, Dinuba, California, United States
πΊπΈLice Source Services, Inc., Plantation, Florida, United States
Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects
- First Posted Date
- 2009-10-14
- Last Posted Date
- 2012-04-06
- Lead Sponsor
- Topaz Pharmaceuticals Inc
- Target Recruit Count
- 264
- Registration Number
- NCT00994422
- Locations
- πΊπΈ
Cactus Kids Pediatrics, Yuma, Arizona, United States
πΊπΈImpact Clinical Trials, Los Angeles, California, United States
πΊπΈLice Cleanique, LLC, Delray Beach, Florida, United States
A Pharmacokinetics (PK) Study in Lice Infested Children 6 Months to 3 Years of Age
- First Posted Date
- 2009-10-02
- Last Posted Date
- 2012-04-25
- Lead Sponsor
- Topaz Pharmaceuticals Inc
- Target Recruit Count
- 30
- Registration Number
- NCT00988533
- Locations
- πΊπΈ
Children's Investigational Research Program, Bentonville, Arkansas, United States
πΊπΈUniversal BioPharma Research, Inc, Dinuba, California, United States
πΊπΈImpact Clinical Trials, Los Angeles, California, United States
Dose Ranging Study of Ivermectin Treatment Conditioner in Subjects With Head Lice Infestation
- Conditions
- Pediculus Humanus Capitis (Head Lice)
- Interventions
- Drug: Placebo, vehicle control
- First Posted Date
- 2009-03-09
- Last Posted Date
- 2012-03-30
- Lead Sponsor
- Topaz Pharmaceuticals Inc
- Target Recruit Count
- 78
- Registration Number
- NCT00857948
- Locations
- πΊπΈ
Global Health Associates of Miami, Miami, Florida, United States